"Один из крупнейших профильных вузов Центрального федерального округа России, который уже более полувека готовит квалифицированные кадры для системы здравоохранения."

During the past decade, Ryazan State Medical University conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 20 clinical trials were completed, i.e. on average, 60.6% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 12 clinical trials were completed. i.e. 52.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ryazan State Medical University" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Ryazan State Medical University" with 6 trials sponsored, "Materia Medica Holding" with 5 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "PHARMENTERPRISES LLC" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ryazan State Medical University" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Chemical Diversity Research Institute" with 1 trials as a collaborator, "EURRUS Biotech GmbH" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Ryazan State Medical University" are "Breast Cancer" (4 trials), "Rheumatoid Arthritis" (4 trials), "Influenza" (3 trials), "Systemic Lupus Erythematosus" (3 trials) and "Type 2 Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Ryazan State Medical University" in a lesser frequency.

Most popular intervention types in "Ryazan State Medical University" are "Drug" (39 trials), "Other" (4 trials), "Procedure" (4 trials), "Behavioral" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "5-Fluorouracil" (3 trials), "Diet" (3 trials), "Docetaxel" (3 trials) and "Exercise" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ryazan State Medical University" are 42 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ryazan State Medical University". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Ryazan State Medical University, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ryazan State Medical University, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".